Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Innis

Showing results (111-120 of 133) with videos related to

Pageof 14
Sort By:
Nuclear Medicine and Biology|April 27, 2001
Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studiesJ K Staley, C H Van Dyck, P Z Tan, et al.
Nuclear Medicine and Biology|January 1, 1996
Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBFC H van Dyck, J P Seibyl, J B Stubbs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjectsM Laruelle, C van Dyck, A Abi-Dargham, et al.
Synapse (New York, N.Y.)|March 1, 1992
Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primatesR B Innis, R T Malison, M al-Tikriti, et al.
Molecular Psychiatry|October 12, 2016
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitorM Fujita, E M Richards, M J Niciu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curvesR B Innis, M S al-Tikriti, S S Zoghbi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transportersJ P Seibyl, M Laruelle, C H van Dyck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1996
SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CITA Abi-Dargham, M S Gandelman, G A DeErausquin, et al.
Psychiatry Research|October 9, 1999
Quantitation of benzodiazepine receptor binding with PET [11C]iomazenil and SPECT [123I]iomazenil: preliminary results of a direct comparison in healthy human subjectsJ D Bremner, R Baldwin, A Horti, et al.
The American Journal of Psychiatry|June 10, 1998
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECTR T Malison, S E Best, C H van Dyck, et al.
Pageof 14

Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Nuclear Medicine and Biology|April 27, 2001
Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studiesJ K Staley, C H Van Dyck, P Z Tan, et al.
Nuclear Medicine and Biology|January 1, 1996
Human biodistribution and dosimetry of the SPECT D2 dopamine receptor radioligand [123I]IBFC H van Dyck, J P Seibyl, J B Stubbs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1994
Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjectsM Laruelle, C van Dyck, A Abi-Dargham, et al.
Synapse (New York, N.Y.)|March 1, 1992
Amphetamine-stimulated dopamine release competes in vivo for [123I]IBZM binding to the D2 receptor in nonhuman primatesR B Innis, R T Malison, M al-Tikriti, et al.
Molecular Psychiatry|October 12, 2016
cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitorM Fujita, E M Richards, M J Niciu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1991
SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curvesR B Innis, M S al-Tikriti, S S Zoghbi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1996
Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transportersJ P Seibyl, M Laruelle, C H van Dyck, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1996
SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CITA Abi-Dargham, M S Gandelman, G A DeErausquin, et al.
Psychiatry Research|October 9, 1999
Quantitation of benzodiazepine receptor binding with PET [11C]iomazenil and SPECT [123I]iomazenil: preliminary results of a direct comparison in healthy human subjectsJ D Bremner, R Baldwin, A Horti, et al.
The American Journal of Psychiatry|June 10, 1998
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECTR T Malison, S E Best, C H van Dyck, et al.
Pageof 14